Sanguinarine Attenuates Lipopolysaccharide-induced Inflammation and Apoptosis by Inhibiting the TLR4/NF-κB Pathway in H9c2 Cardiomyocytes Yan-yan Meng et al, 2018, Current Medical Science CrossRef
miR‐130 aggravates acute myocardial infarction‐induced myocardial injury by targeting PPAR‐γ Xianglin Chu et al, 2018, Journal of Cellular Biochemistry CrossRef
In vitro wound healing of tumor cells: inhibition of cell migration by selected cytotoxic alkaloids Xiaojuan Wang et al, 2019, BMC Pharmacology and Toxicology CrossRef
Sanguinarine Attenuates Neuropathic Pain by Inhibiting P38 MAPK Activated Neuroinflammation in Rat Model
Chao Yu et al, 2020, Drug Design, Development and Therapy CrossRef
Sanguinarine inhibits angiotensin II-induced apoptosis in H9c2 cardiac cells via restoring reactive oxygen species-mediated decreases in the mitochondrial membrane potential YUAN LIU et al, 2015, Molecular Medicine Reports CrossRef
Discovery of Natural Compounds for Cardiac Fibrosis by a Transcriptome-Based Functional Gene Module Reference Approach Wuxia Zhang et al, 2020, Journal of Natural Products CrossRef
Bioactivity and mechanism of action of sanguinarine and its derivatives in the past 10 years Le-Jun Huang et al, 2024, Biomedicine & Pharmacotherapy CrossRef
Phytochemicals as potential IKK-β inhibitor for the treatment of cardiovascular diseases in plant preservation: terpenoids, alkaloids, and quinones Fang Hua et al, 2020, Inflammopharmacology CrossRef
Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway Suxian Zhang et al, 2018, Biomedicine & Pharmacotherapy CrossRef